ARCHIVES

Two-Drug Combination Extends Survival Of Mesothelioma

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Foreeman, Brinker, Jako Appointed To Cancer Panel

April 19, 1991

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983